The store will not work correctly when cookies are disabled.
1-[3-(3-biphenyl)-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)]-3-phenol
ID: ALA209152
PubChem CID: 11537712
Max Phase: Preclinical
Molecular Formula: C22H20N4O
Molecular Weight: 356.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2cccc(-c3ccccc3)c2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C22H20N4O/c1-25(2)22-24-23-21(26(22)19-12-7-13-20(27)15-19)18-11-6-10-17(14-18)16-8-4-3-5-9-16/h3-15,27H,1-2H3
Standard InChI Key: LUUHHLNGWSPYFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.1525 -18.4798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8223 -17.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5591 -17.2009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7295 -17.2076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4790 -17.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5401 -18.3836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5551 -19.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2771 -19.6085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9846 -19.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9656 -18.3522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2430 -17.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1561 -19.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4424 -19.7188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4475 -20.5434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1656 -20.9522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8800 -20.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8714 -19.7071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5990 -20.9358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6679 -17.9240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3925 -18.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0970 -17.8932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0783 -17.0671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3491 -16.6714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6475 -17.1022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6959 -18.2592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0784 -17.7114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5303 -19.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 1 0
16 17 2 0
17 12 1 0
1 12 1 0
8 9 2 0
16 18 1 0
4 5 2 0
9 10 1 0
19 20 2 0
5 1 1 0
20 21 1 0
10 11 2 0
21 22 2 0
11 6 1 0
22 23 1 0
2 6 1 0
23 24 2 0
24 19 1 0
10 19 1 0
2 3 2 0
5 25 1 0
25 26 1 0
12 13 2 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.43 | Molecular Weight (Monoisotopic): 356.1637 | AlogP: 4.37 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.99 | CX Basic pKa: 2.27 | CX LogP: 4.94 | CX LogD: 4.94 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -0.98 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |